Anticoagulation is central to the management of thrombotic antiphospholipid syndrome (APS). The standard anticoagulant treatment for APS life-long warfarin or an alternative vitamin K antagonist. role direct oral anticoagulants not established due lack definitive evidence and has recently been addressed in international guidance. Other options include low molecular weight heparin, unfractionate...